|
2021-03-16 |
2021-03-15 |
S
Sale
|
MONTAGUE WILLIAM P
Non-Executive Director
|
9,033
-8.5%
8.68
USD 78,406
|
9,033
-8.5%
|
8.68
|
USD 78,406
|
|
|
2021-03-15 |
2021-03-15 |
S
Sale
|
Cooke Shane
Non-Executive Director
|
17,290
-18.3%
8.65
USD 149,559
|
17,290
-18.3%
|
8.65
|
USD 149,559
|
|
|
2019-09-17 |
2019-09-16 |
PS
Planned sale
|
KIMMEL ROGER H
|
30,000
-27.3%
4.09
USD 122,700
|
30,000
-27.3%
|
4.09
|
USD 122,700
|
|
|
2019-09-17 |
2019-09-16 |
PS
Planned sale
|
KIMMEL ROGER H
|
25,000
-16.9%
4.09
USD 102,250
|
25,000
-16.9%
|
4.09
|
USD 102,250
|
|
|
2019-06-19 |
2019-06-17 |
PS
Planned sale
|
KIMMEL ROGER H
|
10,000
-8.3%
3.93
USD 39,300
|
10,000
-8.3%
|
3.93
|
USD 39,300
|
|
|
2019-06-19 |
2019-06-17 |
PS
Planned sale
|
KIMMEL ROGER H
|
24,951
-14.4%
3.93
USD 98,057
|
24,951
-14.4%
|
3.93
|
USD 98,057
|
|
|
2018-12-10 |
2018-12-10 |
S
Sale
|
MONTAGUE WILLIAM P
Non-Executive Director
|
10,000
-13.4%
11.41
USD 114,100
|
10,000
-13.4%
|
11.41
|
USD 114,100
|
|
|
2018-11-16 |
2018-11-15 |
PS
Planned sale
|
Hutson Nancy J
Non-Executive Director
|
10,000
-16.7%
12.83
USD 128,300
|
10,000
-16.7%
|
12.83
|
USD 128,300
|
|
|
2018-08-15 |
2018-08-14 |
PS
Planned sale
|
KIMMEL ROGER H
Non-Executive Director
|
14,000
-10.4%
15.90
USD 222,600
|
14,000
-10.4%
|
15.90
|
USD 222,600
|
|
|
2018-08-15 |
2018-08-14 |
PS
Planned sale
|
KIMMEL ROGER H
Non-Executive Director
|
12,074
-7.7%
15.90
USD 191,977
|
12,074
-7.7%
|
15.90
|
USD 191,977
|
|
|
2017-11-17 |
2017-11-15 |
PS
Planned sale
|
KIMMEL ROGER H
|
4,000
-2.9%
6.90
USD 27,600
|
4,000
-2.9%
|
6.90
|
USD 27,600
|
|
|
2017-11-17 |
2017-11-15 |
PS
Planned sale
|
KIMMEL ROGER H
|
5,134
-3.6%
6.90
USD 35,425
|
5,134
-3.6%
|
6.90
|
USD 35,425
|
|
|
2017-08-15 |
2017-08-15 |
B
Purchase
|
Maletta Matthew Joseph
EVP, Chief Legal Officer
|
3,000
+75.3%
8.02
USD 24,060
|
3,000
+75.3%
|
8.02
|
USD 24,060
|
|
|
2017-08-15 |
2017-08-15 |
B
Purchase
|
Coleman Blaise
EVP, Chief Financial Officer
|
6,500
+89.9%
7.89
USD 51,285
|
6,500
+89.9%
|
7.89
|
USD 51,285
|
|
|
2017-08-15 |
2017-08-14 |
B
Purchase
|
Campanelli Paul
President, CEO
Executive Director
|
6,500
+3.1%
7.71
USD 50,115
|
6,500
+3.1%
|
7.71
|
USD 50,115
|
|
|
2017-08-11 |
2017-08-10 |
B
Purchase
|
Coughlin Terrance J
EVP, Chief Operating Officer
|
20,000
+16.6%
7.70
USD 154,000
|
20,000
+16.6%
|
7.70
|
USD 154,000
|
|
|
2017-03-16 |
2017-03-16 |
B
Purchase
|
Campanelli Paul
President, CEO
Executive Director
|
2,300
+1.1%
10.72
USD 24,656
|
2,300
+1.1%
|
10.72
|
USD 24,656
|
|
|
2017-03-10 |
2017-03-09 |
PS
Planned sale
|
Hutson Nancy J
|
5,325
-14.6%
10.82
USD 57,617
|
5,325
-14.6%
|
10.82
|
USD 57,617
|
|
|
2016-11-16 |
2016-11-15 |
PS
Planned sale
|
KIMMEL ROGER H
Non-Executive Director
|
50
-0.0%
18.21
USD 911
|
50
-0.0%
|
18.21
|
USD 911
|
|
|
2016-11-16 |
2016-11-15 |
PS
Planned sale
|
KIMMEL ROGER H
Non-Executive Director
|
6,950
-3.6%
17.37
USD 120,722
|
6,950
-3.6%
|
17.37
|
USD 120,722
|
|
|
2016-11-16 |
2016-11-15 |
PS
Planned sale
|
KIMMEL ROGER H
Non-Executive Director
|
50
-0.1%
18.21
USD 911
|
50
-0.1%
|
18.21
|
USD 911
|
|
|
2016-11-16 |
2016-11-15 |
PS
Planned sale
|
KIMMEL ROGER H
Non-Executive Director
|
6,950
-9.2%
17.37
USD 120,722
|
6,950
-9.2%
|
17.37
|
USD 120,722
|
|
|
2016-05-12 |
2016-05-11 |
B
Purchase
|
HIGGINS ARTHUR J
Non-Executive Director
|
5,000
+11.0%
13.80
USD 69,000
|
5,000
+11.0%
|
13.80
|
USD 69,000
|
|
|
2016-05-11 |
2016-05-10 |
B
Purchase
|
KIMMEL ROGER H
Non-Executive Director
|
5,000
+2.6%
15.48
USD 77,400
|
5,000
+2.6%
|
15.48
|
USD 77,400
|
|
|
2016-05-11 |
2016-05-10 |
B
Purchase
|
KIMMEL ROGER H
Non-Executive Director
|
2,000
+2.7%
15.66
USD 31,320
|
2,000
+2.7%
|
15.66
|
USD 31,320
|
|
|
2016-05-11 |
2016-05-10 |
B
Purchase
|
HIGGINS ARTHUR J
Non-Executive Director
|
11,000
+31.8%
15.42
USD 169,620
|
11,000
+31.8%
|
15.42
|
USD 169,620
|
|
|
2016-05-11 |
2016-05-10 |
B
Purchase
|
Campanelli Paul
Group President, Generics
Officer
|
13,000
+6.9%
15.53
USD 201,890
|
13,000
+6.9%
|
15.53
|
USD 201,890
|
|
|
2016-03-17 |
2016-03-17 |
B
Purchase
|
Spengler William
Non-Executive Director
|
1,000
+2.1%
29.20
USD 29,200
|
1,000
+2.1%
|
29.20
|
USD 29,200
|
|
|
2016-03-16 |
2016-03-16 |
B
Purchase
|
Spengler William
Non-Executive Director
|
1,000
+2.1%
35.24
USD 35,240
|
1,000
+2.1%
|
35.24
|
USD 35,240
|
|
|
2016-03-14 |
2016-03-14 |
B
Purchase
|
KIMMEL ROGER H
Non-Executive Director
|
1,125
+1.6%
41.94
USD 47,183
|
1,125
+1.6%
|
41.94
|
USD 47,183
|
|
|
2016-03-07 |
2016-03-07 |
B
Purchase
|
Maletta Matthew Joseph
Exec. V.P.,Chief Legal Officer
Officer
|
500
+100.0%
44.48
USD 22,240
|
500
+100.0%
|
44.48
|
USD 22,240
|
|
|
2016-03-07 |
2016-03-07 |
B
Purchase
|
DE SILVA RAJIV
President & CEO
Executive Director
|
2,250
+0.9%
44.50
USD 100,125
|
2,250
+0.9%
|
44.50
|
USD 100,125
|
|
|
2016-03-03 |
2016-03-01 |
S
Sale
|
Smith Jill D.
Non-Executive Director
|
3,413
-14.7%
42.19
USD 143,994
|
3,413
-14.7%
|
42.19
|
USD 143,994
|
|
|
2016-03-03 |
2016-03-01 |
S
Sale
|
Spengler William
Non-Executive Director
|
3,413
-6.8%
42.19
USD 143,994
|
3,413
-6.8%
|
42.19
|
USD 143,994
|
|
|
2016-03-03 |
2016-03-01 |
S
Sale
|
Hutson Nancy J
Non-Executive Director
|
3,413
-8.5%
42.19
USD 143,994
|
3,413
-8.5%
|
42.19
|
USD 143,994
|
|
|
2016-03-03 |
2016-03-01 |
S
Sale
|
HYATT MICHAEL
Non-Executive Director
|
3,413
-1.3%
42.19
USD 143,994
|
3,413
-1.3%
|
42.19
|
USD 143,994
|
|
|
2015-11-17 |
2015-11-16 |
B
Purchase
|
KIMMEL ROGER H
Non-Executive Director
|
841
+0.8%
57.00
USD 47,937
|
841
+0.8%
|
57.00
|
USD 47,937
|
|
|
2015-11-12 |
2015-11-12 |
B
Purchase
|
Cooke Shane
Non-Executive Director
|
4,000
+64.7%
57.13
USD 228,520
|
4,000
+64.7%
|
57.13
|
USD 228,520
|
|
|
2015-11-12 |
2015-11-11 |
B
Purchase
|
Upadhyay Suketu
EVP, Chief Financial Officer
Officer
|
3,450
+27.7%
56.68
USD 195,546
|
3,450
+27.7%
|
56.68
|
USD 195,546
|
|
|
2015-11-12 |
2015-11-11 |
B
Purchase
|
Campanelli Paul
President, Par Pharmaceutical
Officer
|
200
+0.1%
56.38
USD 11,276
|
200
+0.1%
|
56.38
|
USD 11,276
|
|
|
2015-11-12 |
2015-11-11 |
S
Sale
|
HYATT MICHAEL
Non-Executive Director
|
8,000
-3.1%
55.48
USD 443,840
|
8,000
-3.1%
|
55.48
|
USD 443,840
|
|
|
2015-11-12 |
2015-11-11 |
B
Purchase
|
Hall Susan
EVP, CSO, Global Head of R&D
Officer
|
1,000
+60.0%
55.35
USD 55,350
|
1,000
+60.0%
|
55.35
|
USD 55,350
|
|
|
2015-11-12 |
2015-11-11 |
B
Purchase
|
Lortie Brian
President Branded Pharma
Officer
|
700
+4.2%
56.47
USD 39,529
|
700
+4.2%
|
56.47
|
USD 39,529
|
|
|
2015-11-12 |
2015-11-11 |
B
Purchase
|
Upadhyay Suketu
EVP, Chief Financial Officer
Officer
|
1,000
+8.7%
55.31
USD 55,310
|
1,000
+8.7%
|
55.31
|
USD 55,310
|
|
|
2015-11-12 |
2015-11-11 |
B
Purchase
|
Campanelli Paul
President, Par Pharmaceutical
Officer
|
1,900
+1.0%
55.62
USD 105,678
|
1,900
+1.0%
|
55.62
|
USD 105,678
|
|
|
2015-11-12 |
2015-11-11 |
B
Purchase
|
Maletta Matthew Joseph
Exec. V.P.,Chief Legal Officer
Officer
|
500
+inf%
56.19
USD 28,095
|
500
+inf%
|
56.19
|
USD 28,095
|
|
|
2015-11-12 |
2015-11-11 |
B
Purchase
|
DE SILVA RAJIV
President & CEO
Executive Director
|
9,006
+5.2%
55.52
USD 500,013
|
9,006
+5.2%
|
55.52
|
USD 500,013
|
|
|
2015-06-18 |
2015-06-16 |
B
Purchase
|
HIGGINS ARTHUR J
Non-Executive Director
|
2,500
+12.3%
81.10
USD 202,750
|
2,500
+12.3%
|
81.10
|
USD 202,750
|
|
|
2015-04-09 |
2015-04-08 |
PS
Planned sale
|
MANOGUE CAROLINE B
Exec. V.P.,Chief Legal Officer
Officer
|
105,059
-70.9%
91.90
USD 9,654,922
|
105,059
-70.9%
|
91.90
|
USD 9,654,922
|
|
|
2015-04-09 |
2015-04-07 |
PS
Planned sale
|
MANOGUE CAROLINE B
Exec. V.P.,Chief Legal Officer
Officer
|
503
-1.2%
91.90
USD 46,226
|
503
-1.2%
|
91.90
|
USD 46,226
|
|
|
2015-03-12 |
2015-03-10 |
S
Sale
|
Farhat Camille
President, AMS, Inc.
Officer
|
8,650
-100.0%
89.39
USD 773,224
|
8,650
-100.0%
|
89.39
|
USD 773,224
|
|
|
2015-03-11 |
2015-03-09 |
S
Sale
|
Farhat Camille
President, AMS, Inc.
Officer
|
40,438
-82.4%
87.02
USD 3,518,915
|
40,438
-82.4%
|
87.02
|
USD 3,518,915
|
|
|
2015-03-09 |
2015-03-05 |
S
Sale
|
MANOGUE CAROLINE B
Exec. V.P.,Chief Legal Officer
Officer
|
42,033
-49.4%
87.78
USD 3,689,657
|
42,033
-49.4%
|
87.78
|
USD 3,689,657
|
|
|
2015-03-06 |
2015-03-04 |
S
Sale
|
Lortie Brian
President Branded Pharma
Officer
|
5,800
-25.7%
85.35
USD 495,030
|
5,800
-25.7%
|
85.35
|
USD 495,030
|
|
|
2014-11-18 |
2014-11-14 |
B
Purchase
|
Upadhyay Suketu
EVP, Chief Financial Officer
Officer
|
3,700
+105.1%
66.94
USD 247,678
|
3,700
+105.1%
|
66.94
|
USD 247,678
|
|
|
2014-08-07 |
2014-08-05 |
B
Purchase
|
HIGGINS ARTHUR J
Non-Executive Director
|
3,500
+65.7%
65.65
USD 229,775
|
3,500
+65.7%
|
65.65
|
USD 229,775
|
|
|
2014-06-10 |
2014-06-09 |
PS
Planned sale
|
DELUCCA JOHN
Non-Executive Director
|
6,764
-19.4%
68.83
USD 465,566
|
6,764
-19.4%
|
68.83
|
USD 465,566
|
|
|
2014-06-02 |
2014-05-29 |
PS
Planned sale
|
MANOGUE CAROLINE B
Exec. V.P., CLO & Secy
Officer
|
175,033
-83.5%
72.02
USD 12,605,877
|
175,033
-83.5%
|
72.02
|
USD 12,605,877
|
|
|
2014-05-02 |
2014-05-01 |
PS
Planned sale
|
DELUCCA JOHN
Non-Executive Director
|
8,094
-27.3%
66.31
USD 536,713
|
8,094
-27.3%
|
66.31
|
USD 536,713
|
|
|
2014-04-02 |
2014-04-01 |
PS
Planned sale
|
DELUCCA JOHN
Non-Executive Director
|
10,384
-32.5%
68.46
USD 710,889
|
10,384
-32.5%
|
68.46
|
USD 710,889
|
|
|
2014-03-11 |
2014-03-10 |
S
Sale
|
Gergel Ivan P.
EVP, R&D and CSO
Officer
|
6,607
-19.3%
72.47
USD 478,809
|
6,607
-19.3%
|
72.47
|
USD 478,809
|
|
|
2014-03-11 |
2014-03-10 |
S
Sale
|
Gergel Ivan P.
EVP, R&D and CSO
Officer
|
22,126
-44.5%
72.47
USD 1,603,471
|
22,126
-44.5%
|
72.47
|
USD 1,603,471
|
|
|
2014-03-11 |
2014-03-10 |
S
Sale
|
Gergel Ivan P.
EVP, R&D and CSO
Officer
|
31,162
-53.0%
72.47
USD 2,258,310
|
31,162
-53.0%
|
72.47
|
USD 2,258,310
|
|
|
2014-03-11 |
2014-03-10 |
S
Sale
|
Gergel Ivan P.
EVP, R&D and CSO
Officer
|
15,742
-36.3%
72.47
USD 1,140,823
|
15,742
-36.3%
|
72.47
|
USD 1,140,823
|
|
|
2014-03-11 |
2014-03-10 |
S
Sale
|
Hutson Nancy J
Non-Executive Director
|
5,000
-19.6%
72.12
USD 360,600
|
5,000
-19.6%
|
72.12
|
USD 360,600
|
|
|
2014-03-11 |
2014-03-10 |
B
Purchase
|
HIGGINS ARTHUR J
Non-Executive Director
|
5,000
+inf%
73.00
USD 365,000
|
5,000
+inf%
|
73.00
|
USD 365,000
|
|
